<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38342315</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7492</ISSN><JournalIssue CitedMedium="Internet"><Volume>342</Volume><PubDate><Year>2024</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Virus research</Title><ISOAbbreviation>Virus Res</ISOAbbreviation></Journal><ArticleTitle>Inhibition of EV71 replication by an interferon-stimulated gene product L3HYPDH.</ArticleTitle><Pagination><StartPage>199336</StartPage><MedlinePgn>199336</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">199336</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virusres.2024.199336</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0168-1702(24)00029-7</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) is the common causative agent of hand-foot-mouth disease (HFMD). Despite evidence in mice model suggested that the interferon (IFN) signaling pathways play a role in defending against this virus, knowledge on the IFN-mediated antiviral response is still limited. Here we identified an IFN-stimulated gene (ISG) called L3HYPDH, whose expression inhibits EV71 replication. Mapping assay indicated that amino acids 61-120 and 295-354 are critical for its optimal antiviral activity. Mechanismly, L3HYPDH specifically inhibits protein translation mediated by EV71 internal ribosome entry site (IRES). Our data thus uncovered a new mechanism utilized by the host cell to restrict EV71 replication.</AbstractText><CopyrightInformation>Copyright © 2024. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Human Virology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou 510080, China; Key Laboratory of Tropical Disease Control (Sun Yat-Sen University), Ministry of Education, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Logen</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Human Virology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou 510080, China; Key Laboratory of Tropical Disease Control (Sun Yat-Sen University), Ministry of Education, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Shinuan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Human Virology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou 510080, China; Key Laboratory of Tropical Disease Control (Sun Yat-Sen University), Ministry of Education, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Xiaobin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Meizhou People's Hospital, Meizhou 514031, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Nanfeng</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Meizhou People's Hospital, Meizhou 514031, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Hai</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Meizhou People's Hospital, Meizhou 514031, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Runcai</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Human Virology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou 510080, China; Key Laboratory of Tropical Disease Control (Sun Yat-Sen University), Ministry of Education, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mu</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, China; Tianjin University and Health-Biotech United Group Joint Laboratory of Innovative Drug Development and Translational Medicine, Tianjin University, Tianjin 300072, China. Electronic address: xin_mu@tju.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Xuemin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute of Human Virology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou 510080, China; Key Laboratory of Tropical Disease Control (Sun Yat-Sen University), Ministry of Education, Guangzhou, Guangdong, China; Meizhou People's Hospital, Meizhou 514031, China; Guangdong Engineering Technological Research Center of Clinical Molecular Diagnosis and Antibody Drugs, Meizhou 514031, China. Electronic address: guoxuemin@mzrmyy.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Virus Res</MedlineTA><NlmUniqueID>8410979</NlmUniqueID><ISSNLinking>0168-1702</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9008-11-1</RegistryNumber><NameOfSubstance UI="D007372">Interferons</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000596">Amino Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007372" MajorTopicYN="Y">Interferons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000596" MajorTopicYN="N">Amino Acids</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antiviral activity</Keyword><Keyword MajorTopicYN="N">Enterovirus 71</Keyword><Keyword MajorTopicYN="N">Interferon-stimulated gene</Keyword><Keyword MajorTopicYN="N">L3HYPDH</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>12</Day><Hour>5</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>11</Day><Hour>19</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38342315</ArticleId><ArticleId IdType="pmc">PMC10875296</ArticleId><ArticleId IdType="doi">10.1016/j.virusres.2024.199336</ArticleId><ArticleId IdType="pii">S0168-1702(24)00029-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Andreev D.E., Fernandez-Miragall O., Ramajo J., Dmitriev S.E., Terenin I.M., Martinez-Salas E., Shatsky I.N. Differential factor requirement to assemble translation initiation complexes at the alternative start codons of foot-and-mouth disease virus RNA. RNA. 2007;13:1366–1374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1924898</ArticleId><ArticleId IdType="pubmed">17592045</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown B.A., Oberste M.S., Alexander J.P., Kennett M.L., Pallansch M.A. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J. Virol. 1999;73:9969–9975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC113047</ArticleId><ArticleId IdType="pubmed">10559310</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang M., Wang X., Wang Q., Wang Y., Lin J., Sun Y., Li X., Zhang L., Lou Z., Wang J., Rao Z. Molecular mechanism of SCARB2-mediated attachment and uncoating of EV71. Protein Cell. 2014;5:692–703.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4145081</ArticleId><ArticleId IdType="pubmed">24986489</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito S., Principi N. Hand, foot and mouth disease: current knowledge on clinical manifestations, epidemiology, aetiology and prevention. Eur. J. Clin. Microbiol. Infect. Dis. 2018;37:391–398.</Citation><ArticleIdList><ArticleId IdType="pubmed">29411190</ArticleId></ArticleIdList></Reference><Reference><Citation>Francisco-Velilla R., Embarc-Buh A., Abellan S., Martinez-Salas E. Picornavirus translation strategies. FEBS Open Bio. 2022;12:1125–1141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9157412</ArticleId><ArticleId IdType="pubmed">35313388</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo X., Zeng S., Ji X., Meng X., Lei N., Yang H., Mu X. Type I interferon-induced TMEM106A blocks attachment of EV-A71 virus by interacting with the membrane protein SCARB2. Front. Immunol. 2022;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8963425</ArticleId><ArticleId IdType="pubmed">35359978</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda M., Ping L.-H, Rijnbrand R.C.A., Amphlett E., Clarke B., Rowlands D., Lemon S.M. Structural Requirements for initiation of translation by internal ribosome entry within genome-length hepatitis C virus RNA. Virology. 1996;222:31–42.</Citation><ArticleIdList><ArticleId IdType="pubmed">8806485</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornung V., Rothenfusser S., Britsch S., Krug A., Jahrsdörfer B., Giese T., Endres S., Hartmann G. Quantitative expression of toll-like receptor 1–10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 2002;168:4531–4537.</Citation><ArticleIdList><ArticleId IdType="pubmed">11970999</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao X.-Y., Guo L., Huang D.-Y, Chang X.-L., Qiu Q.-C. Distribution of EV71 receptors SCARB2 and PSGL-1 in human tissues. Virus Res. 2014;190:40–52.</Citation><ArticleIdList><ArticleId IdType="pubmed">24997419</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai M.-C., Chen H.-H., Xu P., Wang R.Y.L. Translation control of enterovirus A71 gene expression. J. Biomed. Sci. 2020;27:22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6947814</ArticleId><ArticleId IdType="pubmed">31910851</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Liu X., Ma Y., Sun Z., Yang Y., Jin Q., He B., Wang J. The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J. Virol. 2010;84:8051–8061.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2916543</ArticleId><ArticleId IdType="pubmed">20519382</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Sun Z., Liu X., Jin Q., He B., Wang J. Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by toll-like receptor 3. J. Virol. 2011;85:8811–8818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3165803</ArticleId><ArticleId IdType="pubmed">21697485</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K., Zhou S., Guo Q., Chen X., Lai D., Lun Z., Guo X. The eIF3 complex of Trypanosoma brucei : composition conservation does not imply the conservation of structural assembly and subunits function. RNA. 2017;23:333–345.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5311491</ArticleId><ArticleId IdType="pubmed">27932584</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin H., Huang L., Zhou J., Lin K., Wang H., Xue X., Xia C. Efficacy and safety of interferon-α2b spray in the treatment of hand, foot, and mouth disease: a multicenter, randomized, double-blind trial. Arch. Virol. 2016;161:3073–3080.</Citation><ArticleIdList><ArticleId IdType="pubmed">27518403</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J.-Y., Chen T.-C., Weng K.-F., Chang S.-C., Chen L.-L, Shih S.-R. Viral and host proteins involved in picornavirus life cycle. J. Biomed. Sci. 2009;16:103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2785775</ArticleId><ArticleId IdType="pubmed">19925687</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J.Y., Huang H.I. Autophagy is induced and supports virus replication in enterovirus A71-infected human primary neuronal cells. Sci. Rep. 2020;10(1):15234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7499237</ArticleId><ArticleId IdType="pubmed">32943650</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J., Yi L., Zhao J., Yu J., Chen Y., Lin M.C., Kung H.-F., He M.-L. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J. Virol. 2012;86:3767–3776.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3302529</ArticleId><ArticleId IdType="pubmed">22258259</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Salas E., Francisco-Velilla R., Fernandez-Chamorro J., Embarek A.M. Insights into structural and mechanistic features of viral IRES elements. Front. Microbiol. 2018;8:2629.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5759354</ArticleId><ArticleId IdType="pubmed">29354113</ArticleId></ArticleIdList></Reference><Reference><Citation>Martínez-Salas E., Francisco-Velilla R., Fernandez-Chamorro J., Lozano G., Diaz-Toledano R. Picornavirus IRES elements: RNA structure and host protein interactions. Virus Res. 2015;206:62–73.</Citation><ArticleIdList><ArticleId IdType="pubmed">25617758</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuda T., Cepko C.L. Electroporation and RNA interference in the rodent retina in vivo and in vitro. Proc. Natl. Acad. Sci. USA. 2004;101:16–22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC314130</ArticleId><ArticleId IdType="pubmed">14603031</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarry M., Vitour D., Zientara S., Bakkali Kassimi L., Blaise-Boisseau S. Foot-and-mouth disease virus: molecular interplays with IFN response and the importance of the model. Viruses. 2022;14:2129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9610432</ArticleId><ArticleId IdType="pubmed">36298684</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoggins J.W. Interferon-stimulated genes: what do they all do? Annu. Rev. Virol. 2019;6:567–584.</Citation><ArticleIdList><ArticleId IdType="pubmed">31283436</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoggins J.W., Rice C.M. Interferon-stimulated genes and their antiviral effector functions. Curr. Opin. Virol. 2011;1:519–525.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3274382</ArticleId><ArticleId IdType="pubmed">22328912</ArticleId></ArticleIdList></Reference><Reference><Citation>Swain S.K., Panda S., Sahu B.P., Sarangi R. Activation of host cellular signaling and mechanism of enterovirus 71 viral proteins associated with hand, foot and mouth disease. Viruses. 2022;14:2190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9609926</ArticleId><ArticleId IdType="pubmed">36298746</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Y.W., Yam W.K., Kooi R.J.W., Westman J., Arbrandt G., Chu J.J.H. Novel capsid binder and PI4KIIIbeta inhibitors for EV-A71 replication inhibition. Sci. Rep. 2021;11(1):9719.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8102518</ArticleId><ArticleId IdType="pubmed">33958691</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang W.-F., Huang R.-T., Chien K.-Y., Huang J.-Y., Lau K.-S., Jheng J.-R., Chiu C.-H., Wu T.-Y., Chen C.-Y., Horng J.-T. Host MicroRNA miR-197 plays a negative regulatory role in the enterovirus 71 infectious cycle by targeting the RAN protein. J. Virol. 2016;90:1424–1438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4719623</ArticleId><ArticleId IdType="pubmed">26581983</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser W.F., Verhoeven-Duif N.M., de Koning T.J. Identification of a human trans-3-hydroxy-l-proline dehydratase, the first characterized member of a novel family of proline racemase-like enzymes. J. Biol. Chem. 2012;287:21654–21662.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3381129</ArticleId><ArticleId IdType="pubmed">22528483</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X., Chen J., Lu Z., Huang S., Zhang S., Cai J., Zhou Y., Cao G., Yu J., Qin Z., Zhao W., Zhang B., Zhu L. Enterovirus A71 utilizes host cell lipid β-oxidation to promote its replication. Front. Microbiol. 2022;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9554258</ArticleId><ArticleId IdType="pubmed">36246276</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi L., He Y., Chen Y., Kung H.-F., He M.-L. Potent inhibition of human enterovirus 71 replication by type I interferon subtypes. Antivir. Ther. 2011;16:51–58.</Citation><ArticleIdList><ArticleId IdType="pubmed">21311108</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng S., Meng X., Huang Q., Lei N., Zeng L., Jiang X., Guo X. Spiramycin and azithromycin, safe for administration to children, exert antiviral activity against enterovirus A71 in vitro and in vivo. Int. J. Antimicrob. Agents. 2019;53:362–369.</Citation><ArticleIdList><ArticleId IdType="pubmed">30599241</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Yang P., Wang N., Zhang J., Li J., Guo H., Yin X., Rao Z., Wang X., Zhang L. The binding of a monoclonal antibody to the apical region of SCARB2 blocks EV71 infection. Protein Cell. 2017;8:590–600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5546930</ArticleId><ArticleId IdType="pubmed">28447294</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Yang W., Wang X., Zhang X., Tian H., Deng H., Zhang L., Gao G. Identification of new type I interferon-stimulated genes and investigation of their involvement in IFN-β activation. Protein Cell. 2018;9:799–807.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6107486</ArticleId><ArticleId IdType="pubmed">29427062</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S., Chen X., Meng X., Zhang G., Wang J., Zhou D., Guo X. ``Roar” of blaNDM-1 and “silence” of blaOXA-58 co-exist in Acinetobacter pittii. Sci. Rep. 2015;5:8976.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5155454</ArticleId><ArticleId IdType="pubmed">25755005</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y., Wang X., Goff S.P., Gao G. Translational repression precedes and is required for ZAP-mediated mRNA decay: ZAP-mediated translational repression versus mRNA decay. EMBO J. 2012;31:4236–4246.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3492732</ArticleId><ArticleId IdType="pubmed">23023399</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>